Mucopolysaccharidosis Type IVA

DBCOND0060256Genetic Diseases, InbornNutritional and Metabolic Diseases

Mucopolysaccharidosis Type IVA is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Morquio A Syndrome · Mucopolysaccharidosis IVA · MPS IVA · Mucopolysaccharidosis IVA (Morquio A Syndrome) · Morquio Syndrome A
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0014174ICD-10E76.210SNOMED CT124449003UMLSC0086651

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Mucopolysaccharidosis Type IVA share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In